Tao Y - Search Results

1

Retinal vein changes after treatment with aflibercept and PRP in high-risk proliferative diabetic retinopathy.

Zhao H, Wang J, Li S, Bao Y, Zheng X, Tao Y, Wang H. Zhao H, et al. Among authors: tao y. Front Med (Lausanne). 2023 Mar 9;10:1090964. doi: 10.3389/fmed.2023.1090964. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36968838 Free PMC article.

2

Comparison of Heidelberg retina tomography, optical coherence tomography and Humphrey visual field in early glaucoma diagnosis.

Wang H, Tao Y, Sun XL, Zhuang K. Wang H, et al. Among authors: tao y. J Int Med Res. 2013 Oct;41(5):1594-605. doi: 10.1177/0300060513489474. Epub 2013 Sep 3. J Int Med Res. 2013. PMID: 24003055 Free article.

3

α-Lipoic Acid Treatment Improves Vision-Related Quality of Life in Patients with Dry Age-Related Macular Degeneration.

Tao Y, Jiang P, Wei Y, Wang P, Sun X, Wang H. Tao Y, et al. Tohoku J Exp Med. 2016 Nov;240(3):209-214. doi: 10.1620/tjem.240.209. Tohoku J Exp Med. 2016. PMID: 27840374 Free article. Clinical Trial.

4

Effect of green flickering light on myopia development and expression of M1 muscarinic acetylcholine receptor in guinea pigs.

Tao Y, Li XL, Sun LY, Wei YH, Yu XT, Wang H. Tao Y, et al. Int J Ophthalmol. 2018 Nov 18;11(11):1755-1760. doi: 10.18240/ijo.2018.11.04. eCollection 2018. Int J Ophthalmol. 2018. PMID: 30450304 Free PMC article.

5

Short-term effect of intravitreal conbercept injection on major and macular branch retinal vein occlusion.

Tao Y, Huang C, Liu M, Sun L, Li L, Wei Y, Yu X, Wang H. Tao Y, et al. J Int Med Res. 2019 Mar;47(3):1202-1209. doi: 10.1177/0300060518819613. Epub 2019 Jan 25. J Int Med Res. 2019. PMID: 30678515 Free PMC article.

6

Different conbercept injection strategies for the treatment of exudative age-related macular degeneration: A retrospective cohort study.

Gao L, Tao Y, Liu M, Li L, Zhang P, Wang H, Zhang L. Gao L, et al. Among authors: tao y. Medicine (Baltimore). 2020 Feb;99(7):e19007. doi: 10.1097/MD.0000000000019007. Medicine (Baltimore). 2020. PMID: 32049795 Free PMC article.

7

Intravitreal aflibercept partially reverses severe non-proliferative diabetic retinopathy in treatment-naïve patients.

Tao Y, Jiang P, Liu M, Liu Y, Song L, Wang H. Tao Y, et al. J Int Med Res. 2021 Jan;49(1):300060520985369. doi: 10.1177/0300060520985369. J Int Med Res. 2021. PMID: 33499698 Free PMC article.

8

Retrospective study of aflibercept in combination therapy for high-risk proliferative diabetic retinopathy and diabetic maculopathy.

Tao Y, Jiang P, Zhao Y, Song L, Ma Y, Li Y, Wang H. Tao Y, et al. Int Ophthalmol. 2021 Jun;41(6):2157-2165. doi: 10.1007/s10792-021-01773-6. Epub 2021 Mar 27. Int Ophthalmol. 2021. PMID: 33772699 Review.

9

Retinal vein changes in patients with high-risk proliferative diabetic retinopathy treated with conbercept and panretinal photocoagulation co-therapy: a cohort study.

Si M, Tao Y, Zhang Z, Zhao H, Cui W, Yang M, Wang H. Si M, et al. Among authors: tao y. Front Endocrinol (Lausanne). 2023 Aug 25;14:1218442. doi: 10.3389/fendo.2023.1218442. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37693359 Free PMC article.

10

Aflibercept 5+PRN with retinal laser photocoagulation is more effective than retinal laser photocoagulation alone and aflibercept 3+PRN with retinal laser photocoagulation in patients with high-risk proliferative diabetic retinopathy and diabetic macular edema: a 12-month clinical trial.

Li S, Tao Y, Yang M, Zhao H, Si M, Cui W, Wang H. Li S, et al. Among authors: tao y. Front Endocrinol (Lausanne). 2024 Feb 22;15:1286736. doi: 10.3389/fendo.2024.1286736. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38455651 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,486 results

Search Page